Infertility Treatment Market Share, Size & Growth 2031

Get free sample report Request for Customiztion Buy Now

Home
Healthcare
Healthcare & Pharmaceuticals
Infertility Treatment Market Share, Size & Growth 2031

Infertility Treatment Market Share, Size & Growth 2031

Segments - Global Infertility Treatment Market by Types (Equipment, Media & Consumables, and Accessories), Procedures (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgeries, Others), Patient Types (Female Infertility Treatment and Male Infertility Treatment), End-users (Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, and Research Institutes), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

Global Infertility Treatment Market Outlook 2031

The global infertility treatment market size was valued at USD 1.62 billion in 2022 and is expected to surpass USD 3.27 billion by 2031 expanding at a CAGR of 8.1% during the forecast period, 2023–2031. Increasing public-private investments, funds, and grants, as well as a declining fertility rate and a growing number of fertility clinics around the world, are the primary factors driving infertility treatment market.

Infertility refers to a person's inability to reproduce in a natural way. Infertility can be caused by a variety of factors. Increased maternal age, problems related to ovulation, blockage or tubal occlusion, sexually conveyed infections, immunological infertility, heredity, and infertility induced by malefactors are few of the reasons.

Infertility Treatment Market Trends, Drivers, Restraints, and Opportunities:

Factors such as decreased worldwide fertility and increasing number of fertility clinics and hospitals around the globe are expected to rise the infertility treatment market.
Growing advancements in technology, rising public-private sector investments and corporate funding is anticipated to drive the market during the forecast period.
Infertility disorders in men and women are caused by a variety of causes, including a constant shift to a sedentary lifestyle, delayed pregnancy, and poor fetal care, which is projected to boost the market in the coming years.
High price associated with the process for treating infertility is a major factor expected to hinder the market growth during the forecast period.
Lack of experienced personnel and strict government restrictions are two restraint factors that can limit the growth of the infertility treatment market in the coming years.
Emerging markets such as India, China, Brazil, and Mexico are anticipated to offer considerable growth opportunities for the market players.

Scope of The Infertility Treatment Market Report

The report on the global infertility treatment market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Infertility Treatment Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2022
Historic Data	2016-2021
Forecast Period	2023-2031
Segmentation	Types (Equipment, Media & Consumables, and Accessories), Procedures (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgeries, Others), Patient Types (Female Infertility Treatment and Male Infertility Treatment), End-Users (Fertility Centres, Hospitals & Surgical Clinics, Cryobanks, and Research Institutes)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players covered in the Report	Vitrolife, CooperSurgical, Inc., Cook, Thermo Fisher Scientific, FUJIFILM Irvine Scientific., Rocket Medical plc., Hamilton Thorne, Inc., MEDGYN PRODUCTS, INC., Nidacon International AB, and InVitroCare Inc.

Global Infertility Treatment Market Segment Insights

The equipment segment is expected to hold major market share during the forecast period

Based on the products, the market is divided into equipment, media & consumables, and accessories. The equipment segment is expected to account for a key share of the market during the forecast period owing to the presence of well-established companies with a strong product portfolio and increasing technological advancements in the field of infertility treatment.

The assisted reproductive technology segment is projected to account for a significant market share

In terms of procedure, the infertility treatment market is segregated into assisted reproductive technology, artificial insemination, fertility surgeries, and others. The assisted reproductive technology segment is projected to account for a significant share of the market during the forecast period. The rising awareness of assisted reproductive technology (ART), and increasing worldwide acceptance of ART are projected to boost the segment.

The female infertility treatment segment is estimated to grow at a rapid pace

Based on the patient types, the infertility treatment market is bifurcated into female infertility treatment and male infertility treatment. The female infertility treatment segment is estimated to grow at a rapid pace during the forecast period. The female infertility treatment segment is developing due to declining female fertility rates, growing availability of various fertility treatment options, and rising number of fertility facilities around the world.

The fertility centers segment is anticipated to expand at a high CAGR during the forecast period

In terms of end-users, the infertility treatment market is divided into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes. The fertility centers segment is anticipated to expand at a high CAGR during the forecast period. Rising government initiatives to create reproductive clinics, significant international healthcare providers' initiatives to establish fertility centers, and growing popularity of IVF and ICSI treatment globally are projected to drive the market.

North America is anticipated to dominate the market

On the basis of regions, the global infertility treatment market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during forecast period. Increased investments in R&D, high awareness, favorable rules & regulations, reimbursement policies by governmental bodies, increase in health care spending, and other factors contribute to the region’s significant growth in the infertility treatment market.

The market in Asia Pacific is expected to grow at a rapid rate during the projected period. Increased population and awareness, as well as increased governmental and private sector investment support are estimated to propel the market.

Segments

By Product

Equipment
- Microscopes
- Imaging Systems
- Sperm Analyzer Systems
- Ovum Aspiration Pumps
- Micromanipulator Systems
- Incubators
- Gas Analyzers
- Laser Systems
- Cryosystems
Media & Consumables
Accessories

By Procedure

Assisted Reproductive Technology
- In Vitro Fertilization
  - Intracytoplasmic Morphologically Selected Sperm Injection
  - Gamete Donation
- Intracytoplasmic Sperm Injection
- Surrogacy
Artificial Insemination
- Intrauterine Insemination
- Intracervical Insemination
- Intratubal Insemination
Fertility Surgeries
- Laparoscopy
- Hysteroscopy
- Myomectomy
- Laparotomy
- Tubal Ligation Reversal
- Varicocelectomy
- Microsurgical Reconstruction
  - Vasovasostomy
  - Vasoepididymostomy
- Others

By Patient type

Female Infertility Treatment
Male Infertility Treatment

By End-User

Fertility Centers
Hospitals & Surgical Clinics
Cryobanks
Research Institutes

By Regions

Asia Pacific
North America
Europe
Latin America
Middle East & Africa

By Key Players

Vitrolife
CooperSurgical, Inc
Cook
Thermo Fisher Scientific
FUJIFILM Irvine Scientific
Rocket Medical plc
Hamilton Thorne, Inc
MEDGYN PRODUCTS, INC
Nidacon International AB,
InVitroCare Inc

Competitive Landscape

Some of the key players in the infertility treatment market include Vitrolife, CooperSurgical, Inc., Cook, Thermo Fisher Scientific, FUJIFILM Irvine Scientific., Rocket Medical plc., Hamilton Thorne, Inc., MEDGYN PRODUCTS, INC., Nidacon International AB, and InVitroCare Inc.

Infertility Treatment Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Infertility Treatment Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Infertility Treatment Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Infertility Treatment Market - Supply Chain
  4.5. Global Infertility Treatment Market Forecast
     4.5.1. Infertility Treatment Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Infertility Treatment Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Infertility Treatment Market Absolute $ Opportunity
5. Global Infertility Treatment Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Infertility Treatment Market Size and Volume Forecast by End Users
     5.3.1. Fertility Centers
     5.3.2. Hospitals & Surgical Clinics
     5.3.3. Cryobanks
     5.3.4. Research Institutes
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Infertility Treatment Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Infertility Treatment Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Infertility Treatment Demand Share Forecast, 2019-2026
7. North America Infertility Treatment Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Infertility Treatment Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Infertility Treatment Market Size and Volume Forecast by End Users
     7.4.1. Fertility Centers
     7.4.2. Hospitals & Surgical Clinics
     7.4.3. Cryobanks
     7.4.4. Research Institutes
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Infertility Treatment Demand Share Forecast, 2019-2026
8. Latin America Infertility Treatment Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Infertility Treatment Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Infertility Treatment Market Size and Volume Forecast by End Users
     8.4.1. Fertility Centers
     8.4.2. Hospitals & Surgical Clinics
     8.4.3. Cryobanks
     8.4.4. Research Institutes
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Infertility Treatment Demand Share Forecast, 2019-2026
9. Europe Infertility Treatment Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Infertility Treatment Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Infertility Treatment Market Size and Volume Forecast by End Users
     9.4.1. Fertility Centers
     9.4.2. Hospitals & Surgical Clinics
     9.4.3. Cryobanks
     9.4.4. Research Institutes
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Infertility Treatment Demand Share Forecast, 2019-2026
10. Asia Pacific Infertility Treatment Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Infertility Treatment Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Infertility Treatment Market Size and Volume Forecast by End Users
     10.4.1. Fertility Centers
     10.4.2. Hospitals & Surgical Clinics
     10.4.3. Cryobanks
     10.4.4. Research Institutes
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Infertility Treatment Demand Share Forecast, 2019-2026
11. Middle East & Africa Infertility Treatment Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Infertility Treatment Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Infertility Treatment Market Size and Volume Forecast by End Users
     11.4.1. Fertility Centers
     11.4.2. Hospitals & Surgical Clinics
     11.4.3. Cryobanks
     11.4.4. Research Institutes
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Infertility Treatment Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Infertility Treatment Market: Market Share Analysis
  12.2. Infertility Treatment Distributors and Customers
  12.3. Infertility Treatment Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Vitrolife
     12.4.2. CooperSurgical, Inc
     12.4.3. Cook
     12.4.4. Thermo Fisher Scientific
     12.4.5. FUJIFILM Irvine Scientific
     12.4.6. Rocket Medical plc
     12.4.7. Hamilton Thorne, Inc
     12.4.8. MEDGYN PRODUCTS, INC
     12.4.9. Nidacon International AB,
     12.4.10. InVitroCare Inc